KIORA PHARMACEUTICALS INC (KPRX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US49721T5074
KIORA PHARMACEUTICALS INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -12.83 m USD |
| EBIT | -12.99 m USD |
| Net income | -10.84 m USD |
| Diluted EPS – continuing operations | -2.64 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About KIORA PHARMACEUTICALS INC
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has a strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
More stocks
- XWELL, Inc. (XWEL)
- Cardio Diagnostics Holdings, Inc. (CDIO)
- Jaguar Health, Inc. (JAGX)
- HAMMER TECHNOLOGY HOLDINGS CORP. (HMMR)
- Sonoma Pharmaceuticals, Inc. (SNOA)
- QHSLab, Inc. (USAQ)
- Planet Green Holdings Corp. (PLAG)
- SILVERTON ENERGY, INC. (SLTN)
- Two Hands Corp (TWOH)
- Senti Biosciences Holdings, Inc. (SNTI)
- Myseum.AI, Inc. (MYSE)
- LianBio (LIANY)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.